|
|
|
|
|
December 2009 - Earnings outlook causes investors to dump Lilly stock Uncertainty over future earnings when its top-selling drugs come off patent caused investors to sell more than 21 million shares of stock, the largest amount in over two years. Read the article
November 2009 - Steven Paul, head of Lilly's research, to retire Lilly announced that Steven Paul, Executive vice president of Science & Technology and president of Lilly Research Laboratories will retire in February 2010. Read the article
October 2009 - Lilly sells Tippecanoe Laboratories Lilly announces it has sold its Tippecanoe Laboratories facility in Lafayette, IN to Evonik Industries and all 700 full time employees will be offered jobs with Evonik. Read the article
September 14, 2009 - WRTV Channel 6 5:00 pm news
Ed discusses financial issues Lilly employees should
consider in light of the restructuring announcement
September 2009 - Lilly announces companywide restructuring including 5,500 job cuts Lilly announced a series of changes to accelerate the development of new medicines and reduce costs Read the articles
August 2009 - Buyout offer for U.S. sales force Lilly offers a buyout to 4,000 sales representatives with a goal of shrinking their U.S. based sales force by hundreds Read the article
June 2009 - Interview with Bart Peterson An Indianapolis Business Journal interview with Bart Peterson, Eli Lilly's new Senior Vice President of Communication and Community Affairs Read the article
June 2009 - Lilly's economic value to Indiana A study commissioned by Lilly and issued by Indiana University offers a look at the company's economic benefit to the state. The study concludes that Lilly contributed $8.03 billion, or approximately 3.3 percent, to Indiana's gross state product in 2007. Read the article
June 2009 - Bart Peterson to join Lilly Lilly announces that former Indianapolis Mayor Bart Peterson will join Lilly as senior vice president of corporate affairs and communications. To read the announcement click the following link. http://newsroom.lilly.com/releasedetail.cfm?ReleaseID=388207
May 2009 - Pham Exec 50
November 2008 - Pharmaceutical
Executive
|
